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ABSTRACT 
Thyroid hormones (TH) are essential for brain development. However, information on if and 
how this key endocrine factor affects adult neurogenesis is fragmentary. We thus investigated the 
effects of TH on proliferation and apoptosis of stem cells in the subventricular zone (SVZ), as 
well as on migration of transgene-tagged neuroblasts out of the stem cell niche. Hypothyroidism 
significantly reduced all three of these processes, inhibiting generation of new cells. To 
determine the mechanisms relaying TH action in the SVZ, we analyzed which receptor was 
implicated and whether the effects were played out directly at the level of the stem cell 
population. The α TH receptor (TRα), but not TRβ, was found to be expressed in nestin positive 
progenitor cells of the SVZ. Further, use of TRα mutant mice showed TRα to be required to 
maintain full proliferative activity. Finally, a direct TH transcriptional effect, not mediated 
through other cell populations, was revealed by targeted gene transfer to stem cells in vivo. 
Indeed, TH directly modulated transcription from the c-myc promoter reporter construct 
containing a functional TH response element containing TRE but not from a mutated TRE 
sequence. We conclude that liganded-TRα is critical for neurogenesis in the adult mammalian 
brain. 
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nderstanding the genetic regulation of neural stem cell (NSC) maintenance, division, and 
differentiation is a central problem in NSC biology. The identification of subventricular 
astrocytes as NSCs in the subventricular zone (SVZ) of the adult rodent brain 
contributed to the confirmation of the existence of a neurogenic niche in this region (1). 
Although relatively quiescent and slow dividing, the NSC population residing in this site gives 
rise to rapidly dividing neural progenitors, which in turn generate neural precursors that have the 
ability to generate both neurons and glia. However, most cells emerging from the SVZ undergo 
apoptosis (2), while many of the remaining cells migrate to form new interneurons in the 
U 
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 olfactory lobe (3). Some cells may also generate glial cells in the corpus callosum (4). To exploit 
the therapeutic potential of endogenous stem cells, knowledge of the intrinsic and extrinsic 
mechanisms affecting NSC population size and expansion is needed. However, few studies have 
addressed endocrine control of NSC function, particularly in vivo (5). 
The thyroid hormones (TH) are essential for brain development in all vertebrates (6). The main 
secreted form of TH is thyroxine (T4), which is converted to the biologically more active form 
triiodothyronine (T3), in peripheral tissues. In each species studied, TH levels are highest during 
the period of most rapid brain growth and development, which in humans occurs during the first 
2 yr of postnatal life. Lack of TH in early development causes severe neurological damage and 
results in cretinism in man (7). At the cellular level, TH action on specific cells and at specific 
phases of development is known to be a major factor in regulating the timing of proliferation and 
differentiation decisions in a number of neural and nonneural cellular populations including 
retinal progenitors (810), oligodendrocyte precursors (11, 12), and erythroid precursors (13). 
Thus, although it is known that transient exposure of NSCs to TH in vitro initiates a stable switch 
to a glial fate through a direct, instructive mechanism (14), the potential effects of TH on NSC 
proliferation and survival have yet to be characterized in their in vivo context. 
MATERIALS AND METHODS 
Treatment of animals, in vivo transfection, and luciferase assay 
All animal studies were conducted according to the principles and procedures described in 
Guidelines for Care and Use of Experimental Animals. 
To induce hypothyroidism or hyperthyroidism, female OF1 mice (Janvier, Le Genest St. Isle, 
France) were given, respectively, an iodine deficient food containing 0.15% 6-n-propyl-2-
thiouracil (PTU from Harlan Teklad, Madison, WI) or a solution of T3 1.5 µM (Sigma, Saint-
Quentin Fallavier, France) diluted in the drinking water both for 2 wk. To confirm their thyroid 
status, T3 levels in plasma were determined using Amerlex-T3 RIA-kit (Trinity Biotech, 
Wicklow, Ireland). T3 values in PTU-treated, control, and hyperthyroid animals were 19.6 ± 1.9, 
49.4 ± 2.5, and 415.5 ± 35 ng/dl, respectively (means±SE, n= 6 for each group). For evaluating 
T3 effects on reporter gene expression, animals were injected intraperitonealy with 10 µg of 
T3/30 g body wt (in 9 saline). Controls received saline (9) injections. Luciferase activity was 
measured in tissue homogenates as described previously (15). 
Animals 
TRβ−/− mice (16), lacking TRβ1 and TRβ2, and TRα0/0 mice (17), lacking TRα1, TRa2, TR∆α1, 
and TR∆α2, were maintained on a 129/Sv strain. The DNA construct for gene targeting was 
engineered to associate the disruption of the TR gene with an in-frame insertion of the lac-Z 
reporter gene. Wild-type 129/Sv mice were purchased from Charles River Laboratories 
(LArbresle, France). 
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 Plasmid preparation, formulation of polyethylenimine/DNA complexes, and stereotaxic 
injection 
The c-myc promoter fragment (murine origin [-1141/+516] a generous gift from Dr. 
Garcia-Silva from the laboratory of Dr. Aranda, Instituto de Investigaciones Biomedicas 
Alberto Sols, Universidad Autonoma of Madrid, Spain) was inserted in pGl2 basic 
vector from Promega (Madison, WI) upstream of the coding sequence of firefly (Photinus 
pyralis) luciferase. The same promoter fragment was mutated in the TRE using the 
QuickChange XL site-directed mutagenesis kit from (Stratagene) and the primer 5′-
GGGGCGACCTAAGACTGCAGCAATGGAGTGAGAGGGGC-3′. 
Endotoxin-free DNA was prepared using affinity columns (Genomed, Research Triangle Park, 
NC). Plasmid DNA (1 µg per animal) was diluted in 5% glucose to the chosen concentration, 
complexed with 22 kDa linear polyethylenimine (PEI; ratio of 6 PEI nitrogens per DNA 
phosphate, ref 18), and then vortexed. One single injection (5 µl) was performed into either right 
or left lateral ventricle (0.2 mm posterior to bregma line, 1.1 mm lateral, and 2.2 mm deep from 
the pial surface) of 2-mo-old OF-1 mice (Janvier) anaesthetized with 60 mg/kg pentobarbital 
(Sanofi, Paris, France). As previously shown (19), this mode of nonviral plasmid delivery results 
in preferential transfection of adult NSCs and their immediate progeny in the SVZ. Therefore, it 
provides an ideal system to monitor effects of TH on gene expression after PEI-mediated 
transfection. 
To follow migration in the rostral migratory stream (RMS), we performed intraventricular 
injections of PEI complexed plasmid pCMV-LacZ to genetically label NSCs and their progeny 
(19). One week after injections, saggital vibratome sections (80 µm) were prepared and stained 
for β-galactosidase (19). Transgene expressing cells that had migrated from at least 100 µm from 
the ventricle were counted. 
Histological techniques 
Mice were deeply anesthetized with 130 mg/kg pentobarbital (Sanofi) and then sequentially 
perfused (3 ml/min) with saline solution (0.9 NaCl) and 2% paraformaldehyde (PFA). Brains 
were dissected and postfixed in 2% PFA. Immunohistological reactions were performed on 
cryostat sections (10 µm). 
Bromodeoxyuridine (BrdU; Fluka, Saint-Quentin Fallavier, France) was administered in the 
drinking water (1 mg/ml) for 2 wk or by intraperitoneal injection (150 mg/kg) 3 days or 2 h 
before death. 
The 2 wk administration allows labeling of the relatively quiescent population including the 
slow-dividing stem cells. The 3 days pulse of BrdU labels more rapidly proliferating cells. In 
normal conditions, the 3 days chase allows these cells to dilute BrdU, whereas the relatively 
quiescent cells retain the BrdU label (2022). Two hours of BrdU treatment labels actively 
cycling cells. 
BrdU labeling was done using a monoclonal mouse anti-BrdU antibody (Dako, Trappes, France) 
at a 1:50 dilution in PBS containing 1% bovine serum albumin (BSA). Antigenic sites were 
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 unmasked by two microwave cycles (5 min at 750 W, in 10 mM citrate buffer, pH 6). To 
minimize endogenous reactivity with monoclonal antibody, we made use of the Dako ARK 
peroxidase conjugated revelation system (Dako, Trappes, France). 
Polyclonal rabbit antibody anti-phosphorylated histone H3 (Upstate, Lake Placid, NY) was 
applied at a 1:200 dilution. Polyclonal rabbit antibody anti-Ki67 (Novocastra Laboratories, 
Newcastle upon Tyne, UK) was applied at a 1:1000 dilution. Polyclonal rabbit antibody anti-
activated caspase-3 (BD PharMingen, Franklin Lakes, NJ) was applied at a 1:200 dilution. 
For TH receptor detection, we used polyclonal antibodies directed against the TRα1 isoform 
(1:10, overnight, 4°C) and TRβ isoform (see ref 23, 1:50 overnight 4°C) on cryostat sections (10 
µm). The TRα1 antibody was raised against a C-terminal peptide and affinity-purified with the 
same peptide (a gift from Dr. Plateroti, Ecole Normale Supérieure Lyon). Antigenic sites were 
previously unmasked by two microwave cycles (5 min at 750 W, in 10 mM citrate buffer, pH 6). 
The primary monoclonal antibody anti-nestin (BD PharMingen) was applied at 1:500 dilution. 
Triple labeling with either TRα or TRβ (green) on DAPI (1 µg/ml) stained sections (blue nuclei) 
was performed revealing anti-nestin with secondary anti-mouse IgG1 antibody conjugated with 
Cy3 (red) from Sigma. Nestin labeling on β-galactosidase stained cryostat sections (10 µm) of 
TR null mice was revealed using Dako ARK (Dako). 
We used secondary antibody biotinylated anti-rabbit (1:800, 1 h, room temperature) that was 
revealed using extravidin-Cy3 (1:5000, 1 h, room temperature), both from Sigma. We used 
secondary antibody anti-rabbit peroxidase conjugated at 1:200, 1 h, room temperature (Dako). 
Semithin sections of TR null mice were prepared from vibratome sections previously stained 
with a 2 mM BluoGal (Life Technologies, Cergy Pontoise, France) solution as described 
previously (24). 
Statistical analysis of results 
Each set of cell counts (BrdU, PhosH3, Ki67, and caspase-3 positive cells) were performed on 
sections taken from 0.7 to 1.2 mm anterior to bregma and carried out double-blindly by two 
observers. 
In vivo gene transfer and cell counts results are means ± SE per group. After ANOVA analysis 
where appropriate, Kruskal-Wallis test was used to analyze differences between groups. 
Differences were considered significant at P < 0.05. In all cases, typical experiments are shown. 
Each experiment was carried out with n ≥ 6, repeated at least three times, and provided the same 
results. 
RESULTS 
Hypothyroidism reduces NSC proliferation 
We modified the thyroid status of adult mice and examined DNA synthesis and proliferation in 
the SVZ. We used two distinct protocols to label differentially BrdU-incorportating cells. First, 
to label dividing neural progenitors, BrdU was given punctually for 3 days before death. An 
Page 4 of 17
(page number not for citation purposes)
 alternative protocol in which 2 wk BrdU exposure was followed by a 3 day BrdU-free chase 
period was used so as to label slowly proliferating cells. In this protocol, the chase period will 
result in loss, by dilution, of the BrdU signal from the rapidly dividing progenitor population but 
not from the slow-dividing cells or cells that have exited the cell cycle. Induction of 
hypothyroidism by propylthiouracil (PTU) treatment (see Materials and Methods) increased 
numbers of cells in the SVZ-incorporating BrdU in both protocols (Fig. 1A and B). Close 
examination of the labeled cells revealed that hypothyroidism actually resulted in increased 
intensity of the BrdU signal (Fig. 1A, lower panels) in individual cells. This observation suggests 
that once acquired, the BrdU labeling is not diluted by successive cell divisions, indicating that 
cells are either not completing the cell cycle and/or not undergoing further divisions. We 
therefore chose to examine the actual mitotic state of the cells. 
To quantify proliferation, we used the active cell cycle marker Ki67 that labels cells in G1, S, G2, 
and M phases (25) and phosphorylated histone H3 (PhosH3) (2628). PhosH3 increases in G2 
and is maximal in M phase and is rapidly lost as cells enter G1 (27, 29). Hypothyroidism 
significantly reduced PhosH3-positive cells in the SVZ (Fig. 2A–C, P<0.001) and halved the 
number of Ki67 positive cells in the SVZ (Fig. 2D). These apparently contradictory results from 
BrdU and cell cycle markers studies are reconcilable if, in hypothyroidism, cells accumulate 
BrdU but do not re-enter the cell cycle. 
Taken with the data on proliferation, we infer that the increased BrdU labeling seen in 
hypothyroid animals is indicative of increased number of cells that have synthesized DNA but 
have exited the cell cycle. Thus, we further characterized the cell cycling state of resting 
progenitors in the SVZ. We performed double labeling between Ki67 (actively cycling cells) and 
BrdU incorporation after a 3 day BrdU treatment (Fig. 2E). The proportion of cells that have 
synthesized DNA but do not re-enter the cell cycle increases in hypothyroid mice, indicating that 
absence of TH results in accumulation of resting progenitors in the SVZ (Fig. 2F). 
Hypothyroidism limits NSC migration 
To test whether TH affects the migratory capacity of NSC progeny, we used an in vivo gene 
transfer protocol that specifically labels NSC by expression of an exogenous reporter gene. This 
technique exploits PEI, which specifically targets plasmid DNA to the SVZ stem cell and 
neuroprogenitor population in vivo (19). Stereotaxic delivery of PEI-condensed DNA encoding 
lac-Z to the SVZ resulted in β-galactosidase expression in cells in the SVZ and in the RMS (Fig. 
3A and B). Hypothyroidism halved (P<0.05) the numbers of lac-Z expressing cells in the RMS 
(Fig. 3B). 
Apoptosis is the fate of most progenitors arising from NSC division in the SVZ (2). To 
investigate whether thyroid status modifies apoptosis in the SVZ, we followed activated caspase-
3, one of the ultimate players in the apoptosis program (ref 30 and Fig. 3D and E). 
Hypothyroidism halved (P<0.05) the number of caspase-3 positive cells in this region (Fig. 3E). 
Reduction of apoptosis could also contribute to increased numbers of BrdU-labeled cells 
accumulating in the SVZ during hypothyroidism. 
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 TH regulates NSC proliferation through the TRα receptor 
The data so far indicate that TH is required for NSC to pass through mitosis and enter the 
differentiation or apoptosis programs. The question then arises of the mechanisms underlying 
these actions and whether they are direct. TH regulates gene transcription through TH receptors 
that are transcription factors belonging to the steroid hormone/retinoic acid receptor superfamily 
(31). In vertebrates, two genes encode TH receptors, TRα and TRβ (32). Immunocytochemistry 
with TH receptor specific antibodies (see Materials and Methods) showed TRα1, but not TRβ, to 
be expressed in the nestin-expressing cells of the SVZ (Fig. 4A and B). TRα0/0 mice and TRβ−/− 
mice lack all isoforms produced from the TRα or the TRβ loci, respectively (33). To examine 
further TR expression in the SVZ, we used β-galactosidase as a marker for TR-expressing cells 
in TR mutant mice (Fig. 4C and D) and homozygous null mice (Fig. 4E and F). β-galactosidase 
staining reflecting expression from the TRα promoter was strong in the SVZ of TRα mutant 
mice (Fig. 4C, E, and G). In contrast, in TRβ mutant mice no β-galactosidase staining could be 
detected suggesting low or undetectable levels of TRβ expression in this area (Fig. 4D, F, and 
H). β-Galactosidase staining was carried out together with nestin immunochemistry to label the 
SVZ NSCs and progenitor cells in homozygous animals. Noticeably, nestin expression in the 
TRα0/0 mice was markedly reduced (compare Fig. 4I and J) differing from the usual pattern 
recapitulated in TRβ−/− mice, where nestin-positive extensions reach out perpendicularly from the 
SVZ toward the striatum. 
Given the specific expression of TRα in the SVZ, we followed DNA synthesis and mitosis in 
TRα0/0 mice, maintained under euthyroid conditions. BrdU accumulation after a 3 day treatment 
was significantly increased in TRα0/0 mice compared with wild-type counterparts (Fig. 4K–M). 
Inversely, PhosH3-positive cells were halved in TRα0/0 mice (Fig. 4N). Thus, TRα absence 
inhibits progression of NSC through the cell cycle and suggests a role for TRα in mediating TH 
effects on NSC cycling. 
TH directly regulates gene expression and proliferation in the NSC population 
Expression of the TRα gene in the SVZ strongly argues for a direct effect of TH on 
transcriptional regulation in these stem cells. To assess whether this is the case, we used PEI-
mediated gene delivery to introduce into the stem cells a construction containing 1.6 kb of the 
mouse c-myc promoter cloned upstream of the luciferase gene. Hypothyroidism doubled 
transcription from the c-myc promoter, whereas transcription was repressed in animals treated 
with T3 for 2 wk with expression levels not different from controls (Fig. 5A). In a second 
protocol, hypothyroid mice were transfected with c-mycluc and immediately exposed to T3 for 3 
days. Again, in this short T3 exposure experimental paradigm T3 significantly reduced 
transcription from the c-myc promoter in vivo (Fig. 5B). Thus, both long-term (2 wk) and short-
term (36 h) T3 treatment reduce transcription from the c-myc promoter in adult SVZ NSCs and 
their progeny. This TH effect was direct as it was lost if the TRE in the c-myc promoter was 
mutated (Fig. 5B). 
The above findings suggest a direct action of TH on stem cell activity and should implicate a 
rapid response to TH. To estimate the delay of action of TH on proliferation, we went back to a 
BrdU incorporation protocol. However, this time the protocol differed from those used in the 
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 initial experiments in that it was a short, 2 h pulse of BrdU as opposed to a long treatment (2 wk) 
followed or not by a chase. We applied this 2 h BrdU incorporation protocol on hypothyroid 
mice that were injected either with T3 solution for 10 h before death (i.e., 8 h before BrdU 
treatment) or with saline control solution (Fig. 5C and D). With this short pulse of BrdU that 
only labels cells in S phase, we observed significantly more positive cells in euthyroid mice than 
in hypothyroid mice (Fig. 5E). The rapid treatment with T3 fully restored the number of cells in S 
phase to the euthyroid levels (Fig. 5E), again arguing for a direct effect of TH on proliferation. 
DISCUSSION 
Thyroid hormone has long been known to regulate neurodevelopment in all vertebrates. In 
humans, if hypothyroidism occurs early in development (in the fetus or neonate), it causes 
mental retardation and profound deafness. Much work on the complex roles of TH in 
neurodevelopment has shown that TH must act within a critical window of developmental time, 
beyond which hormone replacement cannot recover normal function. Moreover, TH actions are 
widespread, affecting many structures both during early development and later as a maturation 
factor (34). 
Given these key actions of TH during brain development, we chose to analyze whether thyroid 
status affected adult neurogenesis. A first result was that lack of TH severely hampers the 
proliferative potential of the stem cell population in the SVZ of the adult mouse brain. We used a 
number of different protocols to follow the kinetics of DNA synthesis (BrdU accumulation) and 
to quantify the number of cells actually undergoing mitosis at any given time in different thyroid 
states. We show that lack of TH reduces mitotic figures in the SVZ and that a short pulse of TH 
revives the process. This rapid effect of TH on mitotic activity within hours in the SVZ suggests 
that TH is acting directly on the stem cell population. 
A second set of data arguing for a direct effect of TH includes the demonstration of TRα 
expression in the SVZ. These observations exploited deconvolution confocal microscopy on 
wild-type animals and LacZ expression in animals in which this gene had been used as an in-
frame insertion to disrupt the expression of the endogenous TR gene. Further, use of mutant mice 
lacking the TRα receptor showed that absence of this receptor reproduces the effect of 
hypothyroidism on mitotic capacity of SVZ NSCs. Two genes encode the related TRα and TRβ 
receptors across all vertebrate species, suggesting that both genes are essential for TH action. 
Alternative splicing and differential use of promoters produces a variety of isoforms from each 
TR gene, including TRα1, TRα2, TRβ1, and TRβ2. In TRα0/0 mutant mice not only TRα1 is 
absent but also TRα2 and some truncated C-terminal products. However, TRα2 and the 
truncated forms are unable to bind TH and, therefore, TRα1 is the only bona fide TH receptor 
that can mediate T3 neurogenic action in the SVZ. TRα1 presence in the SVZ is revealed by 
immunodetection with the specific anti-TRα1 antibody. In early neurodevelopment, TRα1 is 
widely expressed, whereas TRβ variants are more restricted (34). The role of TRα receptor in 
neurogenesis is underscored by our findings that TRα continues to be expressed in one of the 
few parts of the CNS that maintains a proliferative potential in the adult and that lack of the gene 
products hampers proliferation to the same extent as lack of TH. The data also corroborate 
previous results showing a role for TRα in regulating mitosis in chick embryo neuroblasts (35) 
and the finding that an EST similar to TRα was found in a genomic expression profile of NSC 
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 (36). Another intriguing finding in the TRα0/0 mice is the disruption of nestin expression 
patterns, also observed by Morte et al. (37) using another line of mutant mice lacking specifically 
TRα1. Furthermore, apoptosis, known to be the major fate of NSCs progeny in the SVZ and 
which is probably closely linked to cell cycle to balance proliferation (22), is also affected by 
hypothyroidism. Taken together, these results indicate that not only proliferation but the entire 
organization of the stem cell niche is affected by lack of TH. 
A third line of argument for a direct role of TH on NSC biology comes from the finding that TH 
regulates transcription from a promoter sequence delivered into this population. In these in vivo 
gene transfer experiments, we exploited an approach that had previously been proven to target 
gene transfer to the stem cell population (19) in which we used electron-microscopy to reveal 
triple colocalization of exogenous reporter gene products with mitotic and stem cell markers, 
specifically within stem cells in the adult SVZ. This targeted gene transfer technique thus 
privileges delivery of exogenous genes specifically to the stem cell population. This targeting is 
probably due to their proliferative capacity (38) and/or the expression in the stem cells niche of 
proteoglycans that have been identified as receptors for cationic polyplex delivery (39) and that 
are present on neural precursor cells (40). Using this technique, we find that injecting T3 into 
hypothyroid mice represses transcription from a c-myc promoter-driven luciferase construct 
introduced into the stem cell population. This transcriptional effect must be direct, as it is lost 
when the TH response element in the promoter is mutated. The data are consistent with results 
showing that TH-induced differentiation of neuroblastoma cells is preceded by a rapid decrease 
of c-myc gene expression through a negative T3 responsive element in the promoter (41). Further, 
the finding that transcription from the c-myc promoter is up-regulated in NSC of hypothyroid 
mice could indicate that endogenous c-myc is regulated by TH the NSC. Indeed, given the fact 
that c-myc is known to be a T3 dependent gene and that c-myc regulation is related to cell cycle 
control, it is tempting to speculate that endogenous c-myc may be a key target gene relaying the 
effects of T3 on neural progenitors cycle. 
These in vivo findings show that TH intervenes in the earliest stages of stem cell biology, i.e., in 
the decision to initiate and undergo proliferation. In the SVZ, TH deficiency results in abnormal 
accumulation of BrdU positive cells, indicative of failure to re-enter the cell cycle on the one 
hand and of reduced apoptosis on the other. Similarly, the absence of TRα, normally expressed 
in the SVZ, also blocked cell cycle progression. These data suggest that, besides the well-
established multiple roles of TH in early neurogenesis, TH is an essential component of the 
endocrine environment that activates NSC growth, migration, and apoptosis. Further, the results 
demonstrate that the negative effects of TH on mitotic capacity have repercussions on the 
number of cells migrating through the RMS. Recent work identifies NSCs in the adult human 
brain, which remain relatively quiescent in vivo (42), suggesting the importance of the cellular 
environment to activate stem cells. Endocrine factors such as TH could be key factors to reveal 
regenerative potential of endogenous or grafted stem cells. 
Taken together these findings could have far-reaching clinical implications particularly in an 
aging population that is prone to hypothyroidism. Indeed, hypothyroidism is associated with loss 
of sense of smell in rodents (43) and more importantly, in humans with cognitive decline and 
depression (44, 45). Furthermore, as active neurogenesis is required to see the behavioral effects 
of anti-depressants (46), it is tempting to speculate that the link between hypothyroidism and 
depression could implicate reduced neurogenesis. 
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Fig. 1 
 
                                                  
Figure 1. Hypothyroidism affects BrdU incorporation in SVZ of adult mouse brain. A) Immunohistology of BrdU 
positive cells (dark-brown) in ventricular region of nontreated (left panels), hypothyroid (central), or hyperthyroid (right) 
adult mouse brains. Hypothyroidism increases BrdU incorporation after a 3 day BrdU pulse (upper panels) and after a 2 
wk treatment/3 day chase protocol (middle panels) compared with T3 treatment or controls. At higher magnification (lower 
panels), BrdU labeling in the second protocol appears more intense in hypothyroid animals than in hyperthyroid or 
nontreated controls. Upper and middle panels: bar: 200 µm; lower panels: bar: 40 µm. lv, lateral ventricle. B) 
Quantification of BrdU labeling. In this and the following histograms, means ± SE are given; n = 3-6 animals per group. 
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Figure 2. Hypothyroidism reduces the number of mitotic cells in the SVZ of adult mouse brain: in hypothyroid 
mice BrdU positive cells do not re-enter the cell cycle. A, B) PhosH3 immunodetection (red) with Hoechst 33258 
nuclear staining (blue) in control (A) or hypothyroid animals (B). Bar: A and D: 50 µm; inserts: 20 µm. C) Hypothyroidism 
reduces numbers of phosH3 positive cells compared with control or hyperthyroid animals (***P<0.001). D) 
Hypothyroidism halves Ki67 positive cells compared with controls or hyperthyroid animals (***P<0.001). Each 
experiment was repeated 3 times giving similar results. E) Immunohistology of BrdU-positive cells (red), Ki67 (green) and 
double labeling (merged in yellow) in the ventricular region of nontreated (upper panels), or hypothyroid (lower panels) 
adult mouse brains. F) Hypothyroidism increases the ratio of BrdU positive/Ki67 negative cells after a 3 day BrdU pulse 
compared with controls. Cells were counted from 0.7 to 1.2 mm anterior to bregma for each animal using dichroic 
microscopy. 
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Figure 3. Hypothyroidism decreases numbers of genetically labelled cells entering the rostral migratory stream 
(RMS) and numbers of cells undergoing apoptosis. A–C) pCMV-lac-Z complexed with PEI was transfected by 
intraventricular injection in hypothyroid or control mice. β-Galactosidase-expressing cells in the RMS were quantified 1 
wk later. A) Groups of positive cells are found around the ventricle or migrating via two routes (ventral and dorsal) in 
the RMS toward the olfactory bulb in euthyroid animals (a) but are mainly limited to tarea around the ventricles in 
hypothyroid mice (b). Bar: 500µm. B) Schematic representation of a sagittal section of the adult mouse brain showing the 
lac-Z positive cells migrating in the RMS. The limits of the brain and the main internal structures are indicated in yellow. 
Blue dots represent observed streams of migrating β-galactosidase positive cells (nonquantitative drawing). Bar: 1 mm. C) 
Hypothyroidism reduced numbers of positive cells entering the RMS (*P<0.05). D) Active capsase–3 
immunocytochemistry shows frequent apoptotic cells in a single section of the SVZ. Positive cells were counted from 0.8 
to 1.2 mm anterior to bregma for each animal. Bar: 40 µm. E) PTU treatment significantly reduced numbers of activated 
caspase-3 positive cells. 
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Figure 4. TRα, but not TRβ, is expressed and colocalized with nestin in the SVZ and is required for normal 
progression of NSC through mitosis. A, B) Deconvolution microscopy and immocytochemistry on wild-type mice SVZ 
reveal specifically TRα1 (A) and TRβ (B). TR are labeled green, nestin red, and nuclei blue. Bar: 20µm.  C–F) β-
galactosidase histochemistry (vibratome sections) reveals TRα (C, E) or TRβ (D, F) expressing nuclei in mutant 
heterozygous mice: TRα+/0 (C) and TRβ+/− (D) and homozygous mice TRα0/0 (E) and TRβ−/− (F). Bar: 200 µm. G, H) 
Semithin sections (1 µm) of the SVZ of TRα+/o and TRβ+/−mutant mice. Positive β-galactosidase cells are observed in the 
subependymal layer of the TRα heterozygous mice (G) whereas expression of TRβ in TRβ heterozygous mice is not found 
in the sub-ependymal layer but is only seen more deeply in the striatum (H). Bar: 6 µm. I, J) Nestin immunoreactivity and 
β-galactosidase staining in TR null mice. Note that  nestin expression pattern is reduced and limited to the cell bodies in 
TRα0/0 mice but not in TRβ−/− where typical nestin-positive, long extensions are found (arrows). Bar: 20 µm. K, L) BrdU 
immunochemistry carried out after a 3 day BrdU treatment on TRα0/0 mice shows that TRα absence (L) increases DNA 
synthesis compared with wild type controls (K). Bar: 150µm. M) Quantification of the number of BrdU-labeled cells shows 
a significant increase in TRα0/0 mice (P<0.001). N) PhosH3 immunochemistry shows that absence of TRα results in a 
significant (P>0.001) decrease in the number of mitotic cells in the SVZ. 
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Figure 5. T3 treatment directly represses transcription from the TRE containing c-myc promoter in NSC cells in 
vivo and rapidly reduces the number of cells synthesizing DNA in the SVZ . A, B) Plasmid c-myc-luciferase (0.1 µg) 
complexed with PEI was transfected into the NSC population and progenitors of the SVZ by intraventricular injection. 
Animals were treated with PTU for 2 wk prior to transfection and with T3 for either 3 days (A) or 36 h (B) before death. 
After PTU treatment, luciferase expression was significantly higher (***P<0.001) than that observed in T3 treated or 
control animals. No effect of T3 was seen on the c-myc promoter in which the TRE had been mutated (B, right pair of 
columns). Means ± SE are given; n = 6 animals per group. C–E) BrdU incorporation after a 2 h pulse of BrdU in 
hypothyroid (C) or hypothyroid animals treated with T3 for 10 h (D). Note that a 10 h T3 treatment restores the number of 
cells synthesizing DNA to levels of control, nontreated animals (E). 
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